In addition to the actual task of contraception, hormonal contraceptives (contraception by hormones) have other useful indications.
Additional or secondary indications of hormonal contraceptives:
- Cycle abnormalities or bleeding abnormalities (e.g., polymenorrhea, i.e., the interval between bleeding is less than 25 days; hypermenorrhea, i.e., bleeding is excessive; usually the individual uses more than five pads/tampons per day; menorrhagia, i.e., bleeding is prolonged (> 6 days) and increased)
- Dysmenorrhea
- Acne
- Endometriosis (presence of endometrium (lining of the uterus) outside the uterus, for example, in or on the ovaries (ovaries), tubes (fallopian tubes), urinary bladder, or bowel; use of combined oral contraceptives (COCs) after incomplete surgical endometriosis repair may reduce pain score by 50%)
- Maintenance of bone density in perimenopausal women.
- Improvement impure skin / acne
- Hirsutism (increased terminal hair (long hair) in women, according to the male distribution pattern; androgen-dependent).
- Therapy ovarian hyperandrogenemia / ovary-related excess secretion of male hormones (antiandrogenic progestins).
- Therapy of endometriosis
- Long cycles (avoidance of oligo-amenorrhea (interval between bleeding is greater than 31 days, bleeding occurs too infrequently or no menstrual bleeding for more than three months); by continuous use of monophasic combined oral contraceptives (COCs, COCs).
- Menstrual migraine (migraine that occurs exclusively at the time of menstruation).
- Cycle-dependent headaches
- Premenstrual syndrome (PMS; severe psychological and physical symptoms that occur before the onset of menstrual bleeding) or premenstrual dysphoric disorder (PMDS).
- Reduction in the risk of ovarian and endometrial cancer (cancer of the ovary and endometrium).
- Reduction of the risk for colorectal carcinoma (colon and rectal cancer).
- Uterus myomatosus/uterine fibroids (benign neoplasm of the woman originating from the muscles (myoma) of the uterus (womb)) with bleeding disorders.
- Decrease benign breast disease
